Literature DB >> 28661720

Adaptive B Cell Responses to Influenza Virus Infection in the Lung.

Yoshimasa Takahashi1, Taishi Onodera1, Yu Adachi1, Manabu Ato1.   

Abstract

Adaptive B cell response is a key arm of protective immunity against influenza viruses. Owing to the acutely infectious and cytopathic nature of these viruses, efficient containment of viral spread relies on the prompt provision of protective antibodies to the site of virus infection, the respiratory tract (RT). To accelerate the protective antibody response, B cell responses can be ectopically induced, maintained, and reactivated in the lungs after primary and secondary infection, thereby providing an anatomical advantage in supplying neutralizing antibodies against reinfecting viruses with faster kinetics. However, the prompt supply of protective antibodies may be insufficient to protect against reinfection because influenza viruses can easily change their antigenic profiles to escape antibody surveillance. B cell responses have multiple strategies for adjusting antibody repertoires according to viral fitness, one of which is the formation of local germinal centers capable of selecting B cell repertoires for antigenically subdominant, but conserved, epitopes. In this review, we discuss several unique aspects of B cell responses that take place at local sites to combat acutely infectious and rapidly mutating influenza viruses.

Entities:  

Keywords:  germinal center; influenza; lung; memory B cell

Mesh:

Year:  2017        PMID: 28661720     DOI: 10.1089/vim.2017.0025

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  12 in total

1.  Challenges in estimating influenza vaccine effectiveness.

Authors:  Kylie E C Ainslie; Michael Haber; Walt A Orenstein
Journal:  Expert Rev Vaccines       Date:  2019-05-31       Impact factor: 5.217

Review 2.  Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease.

Authors:  Anshu P Gounder; Adrianus C M Boon
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

3.  Influenza-specific IgG1+ memory B-cell numbers increase upon booster vaccination in healthy adults but not in patients with predominantly antibody deficiency.

Authors:  Gemma E Hartley; Emily S J Edwards; Julian J Bosco; Samar Ojaimi; Robert G Stirling; Paul U Cameron; Katie Flanagan; Magdalena Plebanski; Philip Mark Hogarth; Robyn E O'Hehir; Menno C van Zelm
Journal:  Clin Transl Immunology       Date:  2020-10-16

Review 4.  Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine.

Authors:  Christopher E Lopez; Kevin L Legge
Journal:  Vaccines (Basel)       Date:  2020-08-03

5.  Type I interferon induces CXCL13 to support ectopic germinal center formation.

Authors:  Alice E Denton; Silvia Innocentin; Edward J Carr; Barry M Bradford; Fanny Lafouresse; Neil A Mabbott; Urs Mörbe; Burkhard Ludewig; Joanna R Groom; Kim L Good-Jacobson; Michelle A Linterman
Journal:  J Exp Med       Date:  2019-02-05       Impact factor: 14.307

Review 6.  The Importance of Vaccinating Children and Pregnant Women against Influenza Virus Infection.

Authors:  Ravi S Misra; Jennifer L Nayak
Journal:  Pathogens       Date:  2019-11-26

7.  Evaluation of the peripheral blood T and B cell subsets and IRF-7 variants in adult patients with severe influenza virus infection.

Authors:  Nursel Çalık Başaran; Çağman Tan; Lale Özışık; Begüm Özbek; Ahmet Çağkan İnkaya; Şehnaz Alp; Ebru Ortaç Ersoy; Deniz Çağdaş Ayvaz; İlhan Tezcan
Journal:  Health Sci Rep       Date:  2022-01-20

8.  Elevation in the counts of IL-35-producing B cells infiltrating into lung tissue in mycobacterial infection is associated with the downregulation of Th1/Th17 and upregulation of Foxp3+Treg.

Authors:  Chen Chen; Huan Xu; Ying Peng; Hong Luo; Gui-Xian Huang; Xian-Jin Wu; You-Chao Dai; Hou-Long Luo; Jun-Ai Zhang; Bi-Ying Zheng; Xiang-Ning Zhang; Zheng W Chen; Jun-Fa Xu
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

Review 9.  Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.

Authors:  Cynthia Calzas; Christophe Chevalier
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

Review 10.  Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia.

Authors:  Walter Gottlieb Land
Journal:  Genes Immun       Date:  2021-06-17       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.